APO Research
Talk to an analyst

APO RESEARCH · REPORT

Wearable Injectors and Connected Devices

Compare research editions
View pricing & licenses

Selected research

Industry Research

Wearable Injectors and Connected Devices Industry Research Report 2026

4 July 2026133 pages

Choose your research edition.

Industry ResearchWearable Injectors and Connected Devices Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Wearable Injectors and Connected Devices Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Wearable Injectors and Connected Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Wearable Injectors and Connected Devices Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Wearable Injectors and Connected Devices Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Wearable Injectors and Connected Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Wearable Injectors and Connected Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Wearable Injectors and Connected Devices is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Wearable Injectors and Connected Devices is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Wearable Injectors and Connected Devices include Roche, Ypsomed, West Pharma, United Therapeutics, Unilife Corporation, Sonceboz, ScPharmaceuticals, Owen Mumford and Noble International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Wearable Injectors and Connected Devices market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Wearable Injectors and Connected Devices Market by Company

Roche

Ypsomed

West Pharma

United Therapeutics

Unilife Corporation

Sonceboz

ScPharmaceuticals

Owen Mumford

Noble International

Insulet

Gerresheimer

Enable Injections

Elcam Medical

Eitan Medical

CeQur

BD Medical

Amgen

Wearable Injectors and Connected Devices Segment by Type

Disposable

Reusable

Wearable Injectors and Connected Devices Segment by Application

Home Care Settings

Hospitals

Clinics

Others

Wearable Injectors and Connected Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wearable Injectors and Connected Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Wearable Injectors and Connected Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wearable Injectors and Connected Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Wearable Injectors and Connected Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Wearable Injectors and Connected Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Wearable Injectors and Connected Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Wearable Injectors and Connected Devices Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Wearable Injectors and Connected Devices Sales (k units) of Manufacturers (2021-2026) Table 7. Global Wearable Injectors and Connected Devices Sales Market Share by Manufacturers (2021-2026) Table 8. Global Wearable Injectors and Connected Devices Revenue of Manufacturers (2021-2026) Table 9. Global Wearable Injectors and Connected Devices Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Wearable Injectors and Connected Devices Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Wearable Injectors and Connected Devices Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Wearable Injectors and Connected Devices, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Wearable Injectors and Connected Devices, Product Type & Application Table 14. Global Wearable Injectors and Connected Devices Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Wearable Injectors and Connected Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Roche Company Information Table 19. Roche Business Overview Table 20. Roche Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Roche Wearable Injectors and Connected Devices Product Portfolio Table 22. Roche Recent Developments Table 23. Ypsomed Company Information Table 24. Ypsomed Business Overview Table 25. Ypsomed Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Ypsomed Wearable Injectors and Connected Devices Product Portfolio Table 27. Ypsomed Recent Developments Table 28. West Pharma Company Information Table 29. West Pharma Business Overview Table 30. West Pharma Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. West Pharma Wearable Injectors and Connected Devices Product Portfolio Table 32. West Pharma Recent Developments Table 33. United Therapeutics Company Information Table 34. United Therapeutics Business Overview Table 35. United Therapeutics Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. United Therapeutics Wearable Injectors and Connected Devices Product Portfolio Table 37. United Therapeutics Recent Developments Table 38. Unilife Corporation Company Information Table 39. Unilife Corporation Business Overview Table 40. Unilife Corporation Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Unilife Corporation Wearable Injectors and Connected Devices Product Portfolio Table 42. Unilife Corporation Recent Developments Table 43. Sonceboz Company Information Table 44. Sonceboz Business Overview Table 45. Sonceboz Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Sonceboz Wearable Injectors and Connected Devices Product Portfolio Table 47. Sonceboz Recent Developments Table 48. ScPharmaceuticals Company Information Table 49. ScPharmaceuticals Business Overview Table 50. ScPharmaceuticals Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. ScPharmaceuticals Wearable Injectors and Connected Devices Product Portfolio Table 52. ScPharmaceuticals Recent Developments Table 53. Owen Mumford Company Information Table 54. Owen Mumford Business Overview Table 55. Owen Mumford Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Owen Mumford Wearable Injectors and Connected Devices Product Portfolio Table 57. Owen Mumford Recent Developments Table 58. Noble International Company Information Table 59. Noble International Business Overview Table 60. Noble International Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Noble International Wearable Injectors and Connected Devices Product Portfolio Table 62. Noble International Recent Developments Table 63. Insulet Company Information Table 64. Insulet Business Overview Table 65. Insulet Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Insulet Wearable Injectors and Connected Devices Product Portfolio Table 67. Insulet Recent Developments Table 68. Gerresheimer Company Information Table 69. Gerresheimer Business Overview Table 70. Gerresheimer Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Gerresheimer Wearable Injectors and Connected Devices Product Portfolio Table 72. Gerresheimer Recent Developments Table 73. Enable Injections Company Information Table 74. Enable Injections Business Overview Table 75. Enable Injections Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Enable Injections Wearable Injectors and Connected Devices Product Portfolio Table 77. Enable Injections Recent Developments Table 78. Elcam Medical Company Information Table 79. Elcam Medical Business Overview Table 80. Elcam Medical Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Elcam Medical Wearable Injectors and Connected Devices Product Portfolio Table 82. Elcam Medical Recent Developments Table 83. Eitan Medical Company Information Table 84. Eitan Medical Business Overview Table 85. Eitan Medical Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Eitan Medical Wearable Injectors and Connected Devices Product Portfolio Table 87. Eitan Medical Recent Developments Table 88. CeQur Company Information Table 89. CeQur Business Overview Table 90. CeQur Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. CeQur Wearable Injectors and Connected Devices Product Portfolio Table 92. CeQur Recent Developments Table 93. BD Medical Company Information Table 94. BD Medical Business Overview Table 95. BD Medical Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. BD Medical Wearable Injectors and Connected Devices Product Portfolio Table 97. BD Medical Recent Developments Table 98. Amgen Company Information Table 99. Amgen Business Overview Table 100. Amgen Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Amgen Wearable Injectors and Connected Devices Product Portfolio Table 102. Amgen Recent Developments Table 103. Global Wearable Injectors and Connected Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Wearable Injectors and Connected Devices Sales by Region (2021-2026) & (k units) Table 105. Global Wearable Injectors and Connected Devices Sales Market Share by Region (2021-2026) Table 106. Global Wearable Injectors and Connected Devices Sales by Region (2027-2032) & (k units) Table 107. Global Wearable Injectors and Connected Devices Sales Market Share by Region (2027-2032) Table 108. Global Wearable Injectors and Connected Devices Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Wearable Injectors and Connected Devices Revenue Market Share by Region (2021-2026) Table 110. Global Wearable Injectors and Connected Devices Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Wearable Injectors and Connected Devices Revenue Market Share by Region (2027-2032) Table 112. North America Wearable Injectors and Connected Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units) Table 114. North America Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units) Table 115. North America Wearable Injectors and Connected Devices Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Wearable Injectors and Connected Devices Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Wearable Injectors and Connected Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units) Table 119. Europe Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units) Table 120. Europe Wearable Injectors and Connected Devices Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Wearable Injectors and Connected Devices Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Wearable Injectors and Connected Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units) Table 124. Asia Pacific Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units) Table 125. Asia Pacific Wearable Injectors and Connected Devices Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Wearable Injectors and Connected Devices Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Wearable Injectors and Connected Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units) Table 129. South America Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units) Table 130. South America Wearable Injectors and Connected Devices Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Wearable Injectors and Connected Devices Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Wearable Injectors and Connected Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units) Table 134. Middle East and Africa Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units) Table 135. Middle East and Africa Wearable Injectors and Connected Devices Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Wearable Injectors and Connected Devices Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Wearable Injectors and Connected Devices Sales by Type (2021-2026) & (k units) Table 138. Global Wearable Injectors and Connected Devices Sales by Type (2027-2032) & (k units) Table 139. Global Wearable Injectors and Connected Devices Sales Market Share by Type (2021-2026) Table 140. Global Wearable Injectors and Connected Devices Sales Market Share by Type (2027-2032) Table 141. Global Wearable Injectors and Connected Devices Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Wearable Injectors and Connected Devices Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2021-2026) Table 144. Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2027-2032) Table 145. Global Wearable Injectors and Connected Devices Price by Type (2021-2026) & (USD/unit) Table 146. Global Wearable Injectors and Connected Devices Price by Type (2027-2032) & (USD/unit) Table 147. Global Wearable Injectors and Connected Devices Sales by Application (2021-2026) & (k units) Table 148. Global Wearable Injectors and Connected Devices Sales by Application (2027-2032) & (k units) Table 149. Global Wearable Injectors and Connected Devices Sales Market Share by Application (2021-2026) Table 150. Global Wearable Injectors and Connected Devices Sales Market Share by Application (2027-2032) Table 151. Global Wearable Injectors and Connected Devices Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Wearable Injectors and Connected Devices Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2021-2026) Table 154. Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2027-2032) Table 155. Global Wearable Injectors and Connected Devices Price by Application (2021-2026) & (USD/unit) Table 156. Global Wearable Injectors and Connected Devices Price by Application (2027-2032) & (USD/unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Wearable Injectors and Connected Devices Distributors List Table 160. Wearable Injectors and Connected Devices Customers List Table 161. Wearable Injectors and Connected Devices Industry Trends Table 162. Wearable Injectors and Connected Devices Industry Drivers Table 163. Wearable Injectors and Connected Devices Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Wearable Injectors and Connected Devices Product Image Figure 5. Global Wearable Injectors and Connected Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Wearable Injectors and Connected Devices Market Size (2021-2032) & (US$ Million) Figure 7. Global Wearable Injectors and Connected Devices Sales (2021-2032) & (k units) Figure 8. Global Wearable Injectors and Connected Devices Average Price (USD/unit) & (2021-2032) Figure 9. Disposable Product Image Figure 10. Reusable Product Image Figure 11. Home Care Settings Product Image Figure 12. Hospitals Product Image Figure 13. Clinics Product Image Figure 14. Others Product Image Figure 15. Global Wearable Injectors and Connected Devices Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Wearable Injectors and Connected Devices, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Wearable Injectors and Connected Devices Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Wearable Injectors and Connected Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Wearable Injectors and Connected Devices Sales by Region in 2025 Figure 21. Global Wearable Injectors and Connected Devices Revenue by Region in 2025 Figure 22. North America Wearable Injectors and Connected Devices Market Size by Country in 2025 Figure 23. North America Wearable Injectors and Connected Devices Sales Market Share by Country (2021-2032) Figure 24. North America Wearable Injectors and Connected Devices Revenue Market Share by Country (2021-2032) Figure 25. United States Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Wearable Injectors and Connected Devices Market Size by Country in 2025 Figure 29. Europe Wearable Injectors and Connected Devices Sales Market Share by Country (2021-2032) Figure 30. Europe Wearable Injectors and Connected Devices Revenue Market Share by Country (2021-2032) Figure 31. Germany Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Wearable Injectors and Connected Devices Market Size by Country in 2025 Figure 42. Asia Pacific Wearable Injectors and Connected Devices Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Wearable Injectors and Connected Devices Revenue Market Share by Country (2021-2032) Figure 44. China Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Wearable Injectors and Connected Devices Market Size by Country in 2025 Figure 53. South America Wearable Injectors and Connected Devices Sales Market Share by Country (2021-2032) Figure 54. South America Wearable Injectors and Connected Devices Revenue Market Share by Country (2021-2032) Figure 55. Brazil Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Wearable Injectors and Connected Devices Market Size by Country in 2025 Figure 59. Middle East and Africa Wearable Injectors and Connected Devices Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Wearable Injectors and Connected Devices Revenue Market Share by Country (2021-2032) Figure 61. Egypt Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Wearable Injectors and Connected Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Wearable Injectors and Connected Devices Sales Market Share by Type (2021-2032) Figure 67. Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2021-2032) Figure 68. Global Wearable Injectors and Connected Devices Price (USD/unit) by Type (2021-2032) Figure 69. Global Wearable Injectors and Connected Devices Sales Market Share by Application (2021-2032) Figure 70. Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2021-2032) Figure 71. Global Wearable Injectors and Connected Devices Price (USD/unit) by Application (2021-2032) Figure 72. Wearable Injectors and Connected Devices Value Chain Figure 73. Wearable Injectors and Connected Devices Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Wearable Injectors and Connected Devices Industry Opportunities and Challenges

Scope & coverage.

Types
  • Disposable
  • Reusable
Applications
  • Home Care Settings
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Roche
  • Ypsomed
  • West Pharma
  • United Therapeutics
  • Unilife Corporation
  • Sonceboz
  • ScPharmaceuticals
  • Owen Mumford
  • Noble International
  • Insulet
  • Gerresheimer
  • Enable Injections
  • Elcam Medical
  • Eitan Medical
  • CeQur
  • BD Medical
  • Amgen

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Wearable Injectors and Connected Devices Market Size (2021-2032)
  4. 2.2.2 Global Wearable Injectors and Connected Devices Sales (2021-2032)
  5. 2.2.3 Global Wearable Injectors and Connected Devices Market Average Price (2021-2032)
  6. 2.3 Wearable Injectors and Connected Devices by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Disposable
  9. 2.3.3 Reusable
  10. 2.4 Wearable Injectors and Connected Devices by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Home Care Settings
  13. 2.4.3 Hospitals
  14. 2.4.4 Clinics
  15. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Wearable Injectors and Connected Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Wearable Injectors and Connected Devices Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Wearable Injectors and Connected Devices Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Wearable Injectors and Connected Devices Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Wearable Injectors and Connected Devices Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Wearable Injectors and Connected Devices, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Wearable Injectors and Connected Devices, Product Type & Application
  8. 3.8 Global Manufacturers of Wearable Injectors and Connected Devices, Established Date
  9. 3.9 Global Wearable Injectors and Connected Devices Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Roche
  2. 4.1.1 Roche Company Information
  3. 4.1.2 Roche Business Overview
  4. 4.1.3 Roche Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Roche Wearable Injectors and Connected Devices Product Portfolio
  6. 4.1.5 Roche Recent Developments
  7. 4.2 Ypsomed
  8. 4.2.1 Ypsomed Company Information
  9. 4.2.2 Ypsomed Business Overview
  10. 4.2.3 Ypsomed Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Ypsomed Wearable Injectors and Connected Devices Product Portfolio
  12. 4.2.5 Ypsomed Recent Developments
  13. 4.3 West Pharma
  14. 4.3.1 West Pharma Company Information
  15. 4.3.2 West Pharma Business Overview
  16. 4.3.3 West Pharma Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 West Pharma Wearable Injectors and Connected Devices Product Portfolio
  18. 4.3.5 West Pharma Recent Developments
  19. 4.4 United Therapeutics
  20. 4.4.1 United Therapeutics Company Information
  21. 4.4.2 United Therapeutics Business Overview
  22. 4.4.3 United Therapeutics Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 United Therapeutics Wearable Injectors and Connected Devices Product Portfolio
  24. 4.4.5 United Therapeutics Recent Developments
  25. 4.5 Unilife Corporation
  26. 4.5.1 Unilife Corporation Company Information
  27. 4.5.2 Unilife Corporation Business Overview
  28. 4.5.3 Unilife Corporation Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Unilife Corporation Wearable Injectors and Connected Devices Product Portfolio
  30. 4.5.5 Unilife Corporation Recent Developments
  31. 4.6 Sonceboz
  32. 4.6.1 Sonceboz Company Information
  33. 4.6.2 Sonceboz Business Overview
  34. 4.6.3 Sonceboz Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Sonceboz Wearable Injectors and Connected Devices Product Portfolio
  36. 4.6.5 Sonceboz Recent Developments
  37. 4.7 ScPharmaceuticals
  38. 4.7.1 ScPharmaceuticals Company Information
  39. 4.7.2 ScPharmaceuticals Business Overview
  40. 4.7.3 ScPharmaceuticals Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 ScPharmaceuticals Wearable Injectors and Connected Devices Product Portfolio
  42. 4.7.5 ScPharmaceuticals Recent Developments
  43. 4.8 Owen Mumford
  44. 4.8.1 Owen Mumford Company Information
  45. 4.8.2 Owen Mumford Business Overview
  46. 4.8.3 Owen Mumford Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Owen Mumford Wearable Injectors and Connected Devices Product Portfolio
  48. 4.8.5 Owen Mumford Recent Developments
  49. 4.9 Noble International
  50. 4.9.1 Noble International Company Information
  51. 4.9.2 Noble International Business Overview
  52. 4.9.3 Noble International Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Noble International Wearable Injectors and Connected Devices Product Portfolio
  54. 4.9.5 Noble International Recent Developments
  55. 4.10 Insulet
  56. 4.10.1 Insulet Company Information
  57. 4.10.2 Insulet Business Overview
  58. 4.10.3 Insulet Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Insulet Wearable Injectors and Connected Devices Product Portfolio
  60. 4.10.5 Insulet Recent Developments
  61. 4.11 Gerresheimer
  62. 4.11.1 Gerresheimer Company Information
  63. 4.11.2 Gerresheimer Business Overview
  64. 4.11.3 Gerresheimer Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Gerresheimer Wearable Injectors and Connected Devices Product Portfolio
  66. 4.11.5 Gerresheimer Recent Developments
  67. 4.12 Enable Injections
  68. 4.12.1 Enable Injections Company Information
  69. 4.12.2 Enable Injections Business Overview
  70. 4.12.3 Enable Injections Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Enable Injections Wearable Injectors and Connected Devices Product Portfolio
  72. 4.12.5 Enable Injections Recent Developments
  73. 4.13 Elcam Medical
  74. 4.13.1 Elcam Medical Company Information
  75. 4.13.2 Elcam Medical Business Overview
  76. 4.13.3 Elcam Medical Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Elcam Medical Wearable Injectors and Connected Devices Product Portfolio
  78. 4.13.5 Elcam Medical Recent Developments
  79. 4.14 Eitan Medical
  80. 4.14.1 Eitan Medical Company Information
  81. 4.14.2 Eitan Medical Business Overview
  82. 4.14.3 Eitan Medical Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Eitan Medical Wearable Injectors and Connected Devices Product Portfolio
  84. 4.14.5 Eitan Medical Recent Developments
  85. 4.15 CeQur
  86. 4.15.1 CeQur Company Information
  87. 4.15.2 CeQur Business Overview
  88. 4.15.3 CeQur Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 CeQur Wearable Injectors and Connected Devices Product Portfolio
  90. 4.15.5 CeQur Recent Developments
  91. 4.16 BD Medical
  92. 4.16.1 BD Medical Company Information
  93. 4.16.2 BD Medical Business Overview
  94. 4.16.3 BD Medical Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 BD Medical Wearable Injectors and Connected Devices Product Portfolio
  96. 4.16.5 BD Medical Recent Developments
  97. 4.17 Amgen
  98. 4.17.1 Amgen Company Information
  99. 4.17.2 Amgen Business Overview
  100. 4.17.3 Amgen Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Amgen Wearable Injectors and Connected Devices Product Portfolio
  102. 4.17.5 Amgen Recent Developments
5 Global Wearable Injectors and Connected Devices Market Scenario by Region
  1. 5.1 Global Wearable Injectors and Connected Devices Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Wearable Injectors and Connected Devices Sales by Region: 2021-2032
  3. 5.2.1 Global Wearable Injectors and Connected Devices Sales by Region: 2021-2026
  4. 5.2.2 Global Wearable Injectors and Connected Devices Sales by Region: 2027-2032
  5. 5.3 Global Wearable Injectors and Connected Devices Revenue by Region: 2021-2032
  6. 5.3.1 Global Wearable Injectors and Connected Devices Revenue by Region: 2021-2026
  7. 5.3.2 Global Wearable Injectors and Connected Devices Revenue by Region: 2027-2032
  8. 5.4 North America Wearable Injectors and Connected Devices Market Facts & Figures by Country
  9. 5.4.1 North America Wearable Injectors and Connected Devices Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Wearable Injectors and Connected Devices Sales by Country (2021-2032)
  11. 5.4.3 North America Wearable Injectors and Connected Devices Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Wearable Injectors and Connected Devices Market Facts & Figures by Country
  16. 5.5.1 Europe Wearable Injectors and Connected Devices Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Wearable Injectors and Connected Devices Sales by Country (2021-2032)
  18. 5.5.3 Europe Wearable Injectors and Connected Devices Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Wearable Injectors and Connected Devices Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Wearable Injectors and Connected Devices Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Wearable Injectors and Connected Devices Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Wearable Injectors and Connected Devices Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Wearable Injectors and Connected Devices Market Facts & Figures by Country
  41. 5.7.1 South America Wearable Injectors and Connected Devices Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Wearable Injectors and Connected Devices Sales by Country (2021-2032)
  43. 5.7.3 South America Wearable Injectors and Connected Devices Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Wearable Injectors and Connected Devices Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Wearable Injectors and Connected Devices Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Wearable Injectors and Connected Devices Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Wearable Injectors and Connected Devices Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Wearable Injectors and Connected Devices Sales by Type (2021-2032)
  2. 6.1.1 Global Wearable Injectors and Connected Devices Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Wearable Injectors and Connected Devices Sales Market Share by Type (2021-2032)
  4. 6.2 Global Wearable Injectors and Connected Devices Revenue by Type (2021-2032)
  5. 6.2.1 Global Wearable Injectors and Connected Devices Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Wearable Injectors and Connected Devices Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Wearable Injectors and Connected Devices Sales by Application (2021-2032)
  2. 7.1.1 Global Wearable Injectors and Connected Devices Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Wearable Injectors and Connected Devices Sales Market Share by Application (2021-2032)
  4. 7.2 Global Wearable Injectors and Connected Devices Revenue by Application (2021-2032)
  5. 7.2.1 Global Wearable Injectors and Connected Devices Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Wearable Injectors and Connected Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Wearable Injectors and Connected Devices Value Chain Analysis
  2. 8.1.1 Wearable Injectors and Connected Devices Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Wearable Injectors and Connected Devices Production Mode & Process
  5. 8.2 Wearable Injectors and Connected Devices Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Wearable Injectors and Connected Devices Distributors
  8. 8.2.3 Wearable Injectors and Connected Devices Customers
9 Global Wearable Injectors and Connected Devices Analyzing Market Dynamics
  1. 9.1 Wearable Injectors and Connected Devices Industry Trends
  2. 9.2 Wearable Injectors and Connected Devices Industry Drivers
  3. 9.3 Wearable Injectors and Connected Devices Industry Opportunities and Challenges
  4. 9.4 Wearable Injectors and Connected Devices Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst